MedTrace Logo

123I-MIBG SPECT/CT for Assessment of Cardiac Sympathetic Innervation

NCT00296738 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-08-18

No results posted yet for this study

Summary

Myocardial scintigraphy with 123I-MIBG allows for visual and semi-quantitative assessment of sympathetic cardiac innervation using the hear to mediastinum ratio (HMR). Impaired cardiac MIBG clearance may occur in patients with congestive heart failure (CHF). The purpose of present study was to develop and validate a quantitative index for the assessment of cardiac MIBG uptake kinetics using SPECT/CT for diagnosis of CHF

Conditions

  • Cardiac Diseases

Interventions

DEVICE

SPECT/CT

GE INFINIA HAWKEYE

Sponsors & Collaborators

  • Rambam Health Care Campus

    lead OTHER

Principal Investigators

  • Shmuel Rispler, MD PhD · Rambam Health Care Campus

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2009-08-31
Completion
2010-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00296738 on ClinicalTrials.gov